DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

Pfizer to Buy Two Meningitis Vaccines from Glaxo for $130M - Analyst Blog

The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod - Analyst Blog

ProShares Releases 2 New Leveraged Biotech ETFs

Profit From The Pharma Craze: Sell Gilead, Buy Taro

Can a Growth Stock Also Be a Value Stock?

Most stocks can be classified into either the growth or value category. But, can a growth stock also be a value stock? If these three stocks are any indication, the answer is a resounding "Yes!"

Bristol-Myers' (BMY) Melanoma Drug Opdivo Gets EU Nod - Analyst Blog

Gilead Patent for Sovaldi Rejected in China, Shares Down - Analyst Blog

Where Can Mega-Drug Stock Gilead Sciences Go Now?

Bulls Under The Gun To Muster Troops, While Bears Lie In Wait

Did China Just Crush Gilead Sciences' Dreams?

China has rejected Gilead Sciences' Sovaldi patent application.
See More Articles...